Literature DB >> 2987021

D-ala2-Metenkephalinamide blocks the synaptically elicited cortical spreading depression in rats.

M S Oitzl, V I Koroleva, J Bures.   

Abstract

Spreading depression (SD) was elicited in rats anesthetized with pentobarbital by a train of 8 electrical pulses (0.1 ms, 10 Hz) applied to parietal cortex. Local application of 50 micrograms of D-ala2-metenkephalinamide (DAME) on the stimulated area evoked one or two SD waves followed by an increase of SD threshold from 40 V to 90 V. This effect could be partly prevented by naloxone (1 mg/kg i.p.) and reversed by local application of 4-aminopyridine (10(-3) M, 2 microliters), which reduced SD threshold to 5 and 20 V in normal and DAME-treated cortex, respectively. It is argued that DAME exerts an inhibitory effect on cortical neurons and that the initial SD facilitation is due to initial blockade of inhibitory neurons in the superficial cortical layers.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2987021     DOI: 10.1007/bf02007690

Source DB:  PubMed          Journal:  Experientia        ISSN: 0014-4754


  13 in total

1.  Electrophysiological effects of enkephalin analogs in rat cortex.

Authors:  M R Palmer; D H Morris; D A Taylor; J M Stewart; B J Hoffer
Journal:  Life Sci       Date:  1978-08-28       Impact factor: 5.037

2.  Different brain areas mediate the analgesic and epileptic properties of enkephalin.

Authors:  H Frenk; B C McCarty; J C Liebeskind
Journal:  Science       Date:  1978-04-21       Impact factor: 47.728

3.  The minimum volume of depolarized neural tissue required for triggering cortical spreading depression in rat.

Authors:  T Matsuura; J Bures
Journal:  Exp Brain Res       Date:  1971       Impact factor: 1.972

4.  Development of acute tolerance during exposure of hippocampal explants to an opioid peptide.

Authors:  B H Gähwiler
Journal:  Brain Res       Date:  1981-07-27       Impact factor: 3.252

5.  Effects of opioid peptides on synaptic potentials in explants of rat hippocampus.

Authors:  B H Gähwiler; P L Herrling
Journal:  Regul Pept       Date:  1981-02

6.  Aminopyridines and synaptic transmission.

Authors:  S Thesleff
Journal:  Neuroscience       Date:  1980       Impact factor: 3.590

7.  Cortical penicillin focus as a generator of repetitive spike-triggered waves of spreading depression in rats.

Authors:  V I Koroleva; J Bures
Journal:  Exp Brain Res       Date:  1983       Impact factor: 1.972

8.  The effects of local micro injections of opiates and enkephalins into the forebrain on the electrocorticogram of the rat.

Authors:  H Neal; P E Keane
Journal:  Electroencephalogr Clin Neurophysiol       Date:  1978-11

9.  Potassium-selective microelectrodes used for measuring the extracellular brain potassium during spreading depression and anoxic depolarization in rats.

Authors:  F Vyskocil; N Kritz; J Bures
Journal:  Brain Res       Date:  1972-04-14       Impact factor: 3.252

10.  Spreading depression induced by microinjection of enkephalins into the hippocampus and neocortex.

Authors:  U Sprick; M S Oitzl; K Ornstein; J P Huston
Journal:  Brain Res       Date:  1981-04-06       Impact factor: 3.252

View more
  3 in total

1.  δ-Opioid receptor agonists inhibit migraine-related hyperalgesia, aversive state and cortical spreading depression in mice.

Authors:  Amynah A Pradhan; Monique L Smith; Jekaterina Zyuzin; Andrew Charles
Journal:  Br J Pharmacol       Date:  2014-05       Impact factor: 8.739

2.  Opioid mechanisms involved in the slow potential change and neuronal refractoriness during cortical spreading depression.

Authors:  R C Guedes; F A de Azeredo; T P Hicks; R J Clarke; T Tashiro
Journal:  Exp Brain Res       Date:  1987       Impact factor: 1.972

3.  Forebrain delta opioid receptors regulate the response of delta agonist in models of migraine and opioid-induced hyperalgesia.

Authors:  Isaac J Dripps; Zachariah Bertels; Laura S Moye; Alycia F Tipton; Kendra Siegersma; Serapio M Baca; Brigitte L Kieffer; Amynah A Pradhan
Journal:  Sci Rep       Date:  2020-10-19       Impact factor: 4.996

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.